Q3 EPS Forecast for TransMedics Group Boosted by Analyst

TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) – Equities research analysts at William Blair upped their Q3 2025 earnings per share (EPS) estimates for shares of TransMedics Group in a report released on Thursday, February 27th. William Blair analyst R. Daniels now expects that the company will post earnings of $0.45 per share for the […]

Leave a Reply

Your email address will not be published.

Previous post Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $20.00 at Robert W. Baird
Next post Kinetik (NASDAQ:KNTK) Given New $58.00 Price Target at Wells Fargo & Company